Fri.Jul 12, 2024

article thumbnail

Novo Nordisk's Ozempic cuts dementia risk compared with Merck's Januvia: Oxford study

Fierce Pharma

Trials have already shown that Novo Nordisk’s semaglutide | Trials have already shown that Novo Nordisk’s semaglutide can cut the risk of cardiovascular events and kidney disease. Now a study from the University of Oxford indicates that the company’s semaglutide type 2 diabetes drug Ozempic can reduce the risk of dementia compared with another popular diabetes medicine.

Medicine 314
article thumbnail

What’s Included In HHS’ New Interoperability Proposal?

MedCity News

This week, HHS issued its HTI-2 proposal — a new proposed rule to improve healthcare data sharing among providers, payers, patients and public health organizations. It comes just seven months after HHS issued its HTI-1 rule. The post What’s Included In HHS’ New Interoperability Proposal? appeared first on MedCity News.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Abecma competition, Sotyktu pricing pressure and IRA: Analysts outline Bristol Myers’ top challenges

Fierce Pharma

Several challenges across Bristol Myers Squibb’s business have Leerink Partners analysts worried about the future—despite a few promising growth opportunities the team has identified. | Several challenges across Bristol Myers Squibb’s business have Leerink Partners analysts worried about the drugmaker—despite a few promising growth opportunities they identified.

article thumbnail

Proposed Medicare codes could lift digital health sector

pharmaphorum

A new payment policy proposal released by the Centers for Medicare and Medicaid Services (CMS) this week covers digital tools used for behavioural health, which could be a boost for the digital health sector.The Medicare Physician Fee Schedule (PFS) sets out the method of payment, rates, and codes for healthcare providers participating in Medicare, and is often used by the administration as an instrument to encourage some forms of healthcare intervention.

article thumbnail

AI Strategies for Sales Managers: How to Cut Down on Tedious Admin Work

What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.

article thumbnail

AbbVie's Humira loses some ground in high-stakes battle against biosimilars: report

Fierce Pharma

Even through an onslaught of biosimilar launches that began early last year, AbbVie’s big-selling Humira has been able to retain most of its lucrative market. | With ten biosimilar options in play, AbbVie's star immunology drug lost 13% of its total market share since March, according to a new Samsung Bioepis report.

Marketing 241
article thumbnail

BMS’ long-standing leukemia blockbuster stares down its first generic

PharmaVoice

Patent disputes in the U.S. and abroad have opened the door to new generics ready for launch as soon as September for BMS’ Sprycel.

106
106

More Trending

article thumbnail

Unlocking Hidden Value: Navigating Healthcare Procurement Maturity

MedCity News

The Procurement Maturity Model is more than just a self-assessment tool; it’s an invitation to transform. The post Unlocking Hidden Value: Navigating Healthcare Procurement Maturity appeared first on MedCity News.

article thumbnail

Pfizer selects once-daily GLP-1 for its obesity push

pharmaphorum

Pfizer is advancing on a broad front in its attempt to catch up with Novo Nordisk and Eli Lilly in the obesity drug category – but has now decided on a lead candidate.The company said that, based on a pharmacokinetic study, it has plumped for a once-daily, modified-release formulation of GLP-1 agonist danuglipron that will start dose optimisation studies later this year.

Leads 91
article thumbnail

Cultural Challenges to the Much-Needed Digital Revolution in Healthcare Supply Chain Management

MedCity News

Like in every other industry, AI is knocking on the doors of healthcare with solutions that promise to revolutionize delivery of care. Advancing from a pen-and-paper mindset to a digital revolution will require the use of bridge technology. The post Cultural Challenges to the Much-Needed Digital Revolution in Healthcare Supply Chain Management appeared first on MedCity News.

article thumbnail

NHS rolls out “more convenient” Ocrevus injection for multiple sclerosis

Pharmaceutical Technology

The subcutaneous formulation of Roche’s blockbuster Ocrevus will cut hospital treatment time for patients.

Patients 111
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

Cityblock, Alliance Health Launch Medicaid Partnership in North Carolina

MedCity News

Through a new partnership, Cityblock will offer medical and behavioral health services to members with serious mental illness or substance use disorder in Alliance Health’s Behavioral Health and Intellectual/Development Disability Tailored Plan. The post Cityblock, Alliance Health Launch Medicaid Partnership in North Carolina appeared first on MedCity News.

Medical 94
article thumbnail

Streeting orders “raw and frank” investigation of NHS

pharmaphorum

New UK Health Secretary Wes Streeting orders a 'raw and frank' review of NHS to inform a new 10-year plan to fix it

103
103
article thumbnail

FDA Says ‘No’ to Novo Nordisk’s Once-Weekly Insulin

MedCity News

The FDA rejected Novo Nordisk’s biologics license application for icodec, citing questions about the manufacturing process for this once weekly insulin as well as its use by type 1 diabetes patients. But there are several high-profile FDA approvals in our recap of recent regulatory news. The post FDA Says ‘No’ to Novo Nordisk’s Once-Weekly Insulin appeared first on MedCity News.

FDA 92
article thumbnail

Ipsen gains global rights to Foreseen Biotech’s FS001 ADC

Pharmaceutical Technology

Ipsen has entered an exclusive global licensing agreement with Foreseen Biotech for FS001, a potentially first-in-class ADC.

98
article thumbnail

How to Prove Marketing Value: Demonstrate Content ROI and Contribution to Sales

Every marketer knows how important it is to prove their efforts drive sales opportunities, but that’s easier said than done. When problems like sales and marketing misalignment, lack of data, and wasted efforts persist, marketers can’t measure, prove, or increase their impact on revenue at a time when demonstrating marketing value is critical. Using analyst and expert data, this guide to marketing impact and content attribution explains: How B2B buyers use content The most common types of conten

article thumbnail

Check Out the Roster of Healthcare Innovators Taking Part in INVEST Digital Health in Dallas

MedCity News

The roster of speakers at INVEST Digital Health scheduled for September 18 in Dallas includes executives from health systems, healthcare entrepreneurs, and more. Register today! The post Check Out the Roster of Healthcare Innovators Taking Part in INVEST Digital Health in Dallas appeared first on MedCity News.

article thumbnail

DNA sequencer Element Bio raises $277m to take on Illumina

pharmaphorum

Element Bio’s bid to take on Illumina in the DNA sequencing market has been helped by an impressive $277m financing round

Marketing 100
article thumbnail

Innovate UK grants £4m to four companies to evaluate biomarkers for dementia

PharmaTimes

The progressive neurodegenerative disease affects more than 55 million people globally

94
article thumbnail

Pharma Pulse 7/12/24: The Weight-Loss Gold Rush, GSK Begins Shipping 24-25 Influenza Vaccines & more

Pharmaceutical Commerce

The latest news for pharma industry insiders.

Pharma 105
article thumbnail

Optimizing Clinical Supply Strategy: Navigating Challenges & Finding Your Ideal Model

article thumbnail

Celebrating the 2024 PharmaTimes MSEA and NIEA awards

PharmaTimes

The awards celebrated both medical affairs and nursing professionals in the industry

Medical 91
article thumbnail

The Proposed 2025 Medicare Physician Fee Schedule Has Arrived! Key Takeaways for Digital Health Innovators

Nixon Gwilt Law

The 2025 Medicare Physician Fee Schedule Proposed Rule (the “2025 Proposed Rule”) issued by the Centers for Medicare and Medicaid Services (or “CMS”) on July 10, 2024 contains a number of new policy proposals with significant implications for healthcare innovators. Below is an overview of the most important proposals and the opportunities they present for healthcare innovators and digital health companies.

article thumbnail

UK Researchers developing new tetanus test to identify global immunity gaps

PharmaTimes

The serious, rare condition is responsible for up to 7% of all neonatal deaths globally

Medical 88
article thumbnail

From Winnipeg to Brandon: Exploring Market Opportunities with Manitoba’s Top Doctors

Scott’s Directories

In Manitoba, the healthcare sector thrives, offering vast market opportunities. For businesses targeting this industry, access to a comprehensive physician directory in Manitoba is invaluable. Whether you’re a pharmaceutical company, a medical equipment supplier, or a healthcare recruiter, having a detailed Manitoba medical directory can significantly enhance your outreach efforts.

Doctors 52
article thumbnail

Increase Revenue With Better, Faster Sales Onboarding

Quotas need to be hit. Revenue goals need to be met. This reality makes shortening sales onboarding time a top priority. Organizations with a standard onboarding process boost employee retention by 58% and increase productivity by 50%. Unfortunately, many companies struggle with inefficient processes that lead to high turnover and missed revenue opportunities.

article thumbnail

Cohort Study Compares Weight Loss Effects of Tirzepatide vs. Semaglutide

PharmExec

JAMA study aims to discover how weight loss differs between patients receiving tirzepatide compared with semaglutide among a clinical population of overweight of obese adults.

article thumbnail

Unlocking the Potential of MD Select’s BC Doctors Directory for Pharmaceutical Sales

Scott’s Directories

In the dynamic world of pharmaceutical sales, having access to accurate and comprehensive information is crucial. One of the most valuable resources available to sales professionals is MD Select’s BC Doctors Directory. This directory provides detailed information on physicians across British Columbia, enabling sales teams to target their efforts more effectively.

Doctors 52
article thumbnail

GLC Guerrilla: A Medical Rep's Guide to Bureaucratic Warfare

Contrarian Sales Techniques

Blood, Sweat, and Samples: A Day in the Life of a GLC Medical Rep The fluorescent lights hummed overhead, casting a sterile glow on the tense faces around the conference table. Dr. Hassan, the notoriously critical head of procurement at General Hospital, was dissecting our proposal like a seasoned surgeon. Sweat beaded on my forehead despite the air-conditioning.

Medical 52
article thumbnail

Advanced techniques fuelling demand for liquid chromatography reagents

European Pharmaceutical Review

A report published by Market Expertz predicts that size of the liquid chromatography reagents market will increase by $3,879.72 million between 2022 and 2032. Demand for high-performance liquid chromatography ( HPLC ) reagents and increasing reliance on chromatography techniques in pharmaceuticals and biotechnology applications are key drivers of the liquid chromatography reagents market, the research asserted.

article thumbnail

European Clinical Supply Planning: Balancing Cost, Flexibility and Time

article thumbnail

Why This Doctor Now Prescribes Generics

Contrarian Sales Techniques

Beyond the Brand Name Dr. Elena Reyes was a doctor's doctor. For over two decades, her patients in the quaint town of Harmony Springs trusted her implicitly. Her spotless record and unwavering commitment to their well-being were legendary. One of the things her patients appreciated most was her reliance on brand-name medications. They felt a sense of security knowing they were getting the "gold standard" in treatment.

Doctors 52
article thumbnail

Financial Advisor to Keynote Speaker

Scott Burrows

In the bustling world of finance, where numbers reign supreme and strategies dominate conversations, I found myself drawn to a different kind of currency. The currency of inspiration. Little did I know, a single moment at a conference would spark a journey that would redefine my purpose and passion to become a keynote speaker. In the early ‘90s, I was a Financial Advisor attending a conference with 5,000 other attendees.

article thumbnail

When a Generic Medication Saves the Day

Contrarian Sales Techniques

The Balancing Act Emily, a whirlwind of energy packed into a five-foot frame, was a master of juggling. Single mom? Check. Full-time job? Check. Raising a superhero-obsessed kindergartener named Josh? Check and check. The only thing Emily couldn't quite juggle was the ever-increasing cost of Josh's asthma medication. It had a heroic name – Bronchia-Blast – but its price tag was more villainous than a comic book baddie.

Medical 52
article thumbnail

BARDA and Tiba Biotech link to develop ‘flu therapeutics

Pharmaceutical Technology

Preclinical biopharmaceutical company Tiba Biotech has announced a partnership with BARDA to develop therapeutics against influenza.

59
article thumbnail

Using Generative AI in Sales: Pros, Cons, and Considerations According to Sellers

Are your sellers unsure about using AI in their day-to-day workflows? Or are they eager to try but uncertain where to start? They might be asking: Which tasks are best suited for AI? How will using AI affect my relationship with my customers? With so many tools available, which ones are the most useful to me? To help answer these and other common questions about using AI during the sales cycle, we surveyed B2B sellers who were early adopters to get their insight and advice about how to use gen A